Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Hobson, Michael J ^a   Wong, Hector R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOMODULATING AGENT; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; GAMMA INTERFERON; LIPOPOLYSACCHARIDE;

GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; MONOCYTE; NOTE; PRIORITY JOURNAL; SEPSIS; BLOOD; DRUG EFFECT; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MALE; METABOLISM; METHODOLOGY; SEPTIC SHOCK;

FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; RNA, MESSENGER; SHOCK, SEPTIC;

EID: 83355163586     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10527     Document Type: Note

References (11)

1. Turrel-Davin F, Venet F, Monnin C, Barbalat V, Cerrato E, Pachot A, Lepape A, Alberti-Segui C, Monneret G. mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance. Crit Care 2011, 15:R252. 10.1186/cc10513, 22027436.
2. Hotchkiss RS, Opal S. Immunotherapy for sepsis - a new approach against an ancient foe. N Engl J Med 2010, 363:87-89. 10.1056/NEJMcibr1004371, 20592301.
3. Marshall JC, Reinhart K. Biomarkers of sepsis. Crit Care Med 2009, 37:2290-2298. 10.1097/CCM.0b013e3181a02afc, 19487943.
4. Kaplan JK, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med 2011, 12:165-170. 10.1097/PCC.0b013e3181e28876, 20473243.
5. Marshall JC. The staging of sepsis: understanding heterogeneity in treatment efficacy. Crit Care 2005, 9:626-628. 10.1186/cc3907, 1414009, 16356249.
6. Vincent JL, Opal SM, Marhsall JC. Ten reasons why we should not use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med 2010, 38:283-287. 10.1097/CCM.0b013e3181b785a2, 19730252.
7. Feezor RJ, Cheng A, Paddock HN, Baker HV, Moldawer LL. Functional genomics and gene expression profiling in sepsis: beyond class prediction. Clin Infect Dis 2005, 41(Suppl 7):S427-S435.
8. Wong HR, Wheeler DS, Tegtmeyer K, Poynter SE, Kaplan JM, Chima RS, Stalets E, Basu RK, Doughty LA. Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept. Crit Care Med 2010, 38:1955-1961. 2943553, 20639748.
9. Wheeler DS, Lahni PM, Denenberg AG, Poynter SE, Wong HR, Cook JA, Zingarelli B. Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 2008, 30:267-273. 2754132, 18197145.
10. Wong HR, Cvijanovich N, Wheeler DS, Bigham MT, Monaco M, Odoms K, Macias WL, Williams MD. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008, 178:276-282. 10.1164/rccm.200801-131OC, 2542425, 18511707.
11. Calfee CS, Thompson BT, Parsons PE, Ware LB, Matthay MA, Wong HR. Plasma interleukin-8 is not an effective risk stratification tool for adults with vasopressor-dependent septic shock. Crit Care Med 2010, 38:1436-1441. 10.1097/CCM.0b013e3181de42ad, 20386309.